OpenVSafe by OpenVAERS
Search V-safe

3EZ-15592-10065

5 vaccinations 3 coded responses 29 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
600 / IL
Registered
2021-04-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-04
    Registered in v-safe
  2. 2021-04-04
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-04
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-11
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-19
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-27
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-02
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-02
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  17. 2021-05-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-09
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache
    Adult check-in
  19. 2021-05-16
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-30
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-14
    Survey response — day 42, dose 2
    MedDRA: Chest pain, Heart rate increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Chest pain / fluttering heartbeat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-06-14
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-06-23
  26. 2021-08-02
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-11-07
    Dose 3 — Pfizer-BioNTech
  28. 2022-05-02
    Survey response — 12 months, dose 2
    MedDRA: Surgery, Uterine polyp — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Symptoms: Benign endometrial polyp diagnosed in March 2022 · Healthcare visit (other): Outpatient surgery
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-05-02
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  30. 2022-05-03
  31. 2022-05-07
    Dose 4 — Pfizer-BioNTech
  32. 2022-09-27
    Dose 5 — Pfizer-BioNTech
  33. 2022-10-16
    Health check-in — day 14, dose 5
    Feeling: Fair
    Adult check-in
  34. 2022-10-18
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  35. 2022-10-25
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  36. 2022-11-01
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  37. 2022-11-08
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  38. 2022-12-27
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  39. 2023-03-28
    Survey response — 6 months, dose 5
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-04Pfizer-BioNTech
22021-05-02Pfizer-BioNTech
32021-11-07Pfizer-BioNTech No
42022-05-07Pfizer-BioNTech No
52022-09-27Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-06-14 Unsuccessful
2022-05-02 Unsuccessful

Free text

Release 9 — day 42, dose 2

2021-06-14

Symptoms: Chest pain / fluttering heartbeat

Release 11 — 12 months, dose 2

2022-05-02

Symptoms: Benign endometrial polyp diagnosed in March 2022
Healthcare visit (other): Outpatient surgery

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSurgery · · ✓
SDChest pain ✓ ✓ ✓
SDCOVID-19 · · ✓
SDHeart rate increased ✓ ✓ ✓
SDUterine polyp · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…